A new COVID-19 vaccine study out of Israel claims the Pfizer jabs are effective against variants, according to reports.
"Two doses of BNT162b2 are highly effective across all age groups in preventing symptomatic and asymptomatic SARS-CoV-2 infections and COVID-19-related hospitalizations, severe disease, and death, including those caused by the B.1.1.7 SARS-CoV-2 variant," the study said.The study added the Pfizer vaccine provided 95.3% protection against infection and 96.7% protection against death seven days after the second dose.
Full vaccination mattered as one dose alone gave just 57.7% protection against infection, 75.7% against hospitalization, and 77% against death. "By 14 days after vaccination, protections conferred by a second dose increased to 96.5% protection against infection, 98% against hospitalization, and 98.1% against death," the study said. As of May 5, in Israel, 5.41 million people have received at least one dose of COVID-19 vaccine, 62.55% relative to the population; 5.07 million people fully vaccinated against COVID-19, 58.56% relative to the population.
In terms of countries with the highest percentages of populations vaccinated, Israel ranks as number 3. According to the Johns Hopkins University Coronavirus Resource Center, Israel's vaccinated population is at 55.99% of the total population. Gibraltar is number 1 at 99.73%; Seychelles is number 2 at 61.13%; the United States is number 10 at 30.58%. Other countries in the top 10: the Cayman Islands, the United Arab Emirates, Bermuda, Chile, Bahrain, and San Marino.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid:19: Nisra records slight increase in NI Covid deathsCovid-19 was mentioned on the death certificates of eight people in NI up to Friday 30 April.
Read more »
EU seals new Pfizer deal for 1.8 bln COVID-19 vaccinesThe European Union signed a new contract with Pfizer-Biontech (PFE.N) to receive 1.8 billion doses of COVID-19 vaccines for 2021-2023, to cover booster shots, donations and reselling of doses, the European Commission said on Friday.
Read more »
Pfizer, BioNTech to donate COVID-19 vaccines to Olympic athletesPfizer and BioNTech will be providing COVID-19 vaccines to Olympic athletes participating in the summer games in Tokyo.
Read more »
Teens Aged 12 to 15 Can Now Get Pfizer-BioNTech COVID-19 Vaccine in the U.S.The U.S. Food and Drug Administration (FDA) extended authorization of the Pfizer-BioNTech COVID-19 vaccine to 12- to 15-year-olds. It’s the first COVID-19 shot authorized for this younger population.
Read more »
EU won’t renew AstraZeneca COVID-19 vaccine; Pfizer shot will take precedenceThe European Union hasn’t made any new orders for AstraZeneca’s COVID-19 vaccine beyond June when the contract ends. The EU agreed on a contract extension with Pfizer and BioNTech for a potential 1.8 billion doses through 2023.
Read more »
Pfizer/BioNTech seek full FDA approval for their Covid-19 vaccinePfizer/BioNTech seeks full FDA approval for its Covid-19 vaccine, which is currently available through an emergency use authorization
Read more »